Subscribe

Colleen Moretti

Articles by Colleen Moretti

Axicabtagene Ciloleucel Improves Outcomes in Relapsed/Refractory Follicular Lymphoma

ByColleen Moretti

June 15th 2021

A comparative analysis of the ZUMA-5 and SCHOLAR-5 trials revealed improvements in outcomes over currently available therapies.

Latest Updated Articles

Trending on CGTlive®

Around the Helix: Cell and Gene Therapy Company Updates – November 5, 2025

Quarter Century Update: The Impact of Artificial Intelligence

Guess the Therapy Answer November 5, 2025

© 2025 MJH Life Sciences^®

All rights reserved.